Discover the Latest in Biomedical Research Innovation

Your drug works in wild-type mice and not in the knockout, so the effect depends on the gene. That conclusion does not follow, and in one major review of top journals, half the papers that needed the right test got it wrong. This two-way ANOVA interaction SOP runs the correct analysis in GraphPad Prism, from data entry to a reportable result, with a worked example in which the naive reading and the right answer disagree.

Reviewers examining 100 clinical papers found 65% needed revisions just to explain what their statistical tests were for, and 64% had omitted effect sizes entirely. Statistical reporting problems are rarely about running the wrong analysis; they're about not writing down enough for a reader to judge it. Here's what belongs in the section, built on the SAMPL guidelines: seven things to state in your methods, the results formats that draw fewest queries, and a template you can

Run an ANCOVA and a multiple regression on the same data, specified equivalently, and you get the same F, the same p, and the same coefficients. They are one model with two traditions, and dummy coding is the bridge. So the real question isn't which is correct but which framing makes your result clearest. This piece covers why they're equivalent, what genuinely differs, and how to describe your model so reviewers from either tradition can follow it.

Hunted through Prism's Analyze menu for ANCOVA? It isn't there, and GraphPad's own FAQ confirms they've never shipped one. Prism can still do it, through two documented routes most users never find: the simple-linear-regression slopes test for the parallel-slopes assumption, and multiple regression with dummy-coded groups for the adjusted comparison. Here are both step by step, plus an honest comparison with describing the same analysis in plain language instead.

A perfect scratch becomes unusable if the field drifts out of focus, the illumination shifts between time points, or the wound edges are too low-contrast to segment. The biggest scratch assay imaging mistakes aren't dramatic failures, they're small inconsistencies that quietly distort wound area. This guide covers the imaging principles behind reproducible wound healing assays on any microscope: imaging mode, objectives, Köhler illumination, and locking your optics.

Sophie 4.5 is live. It keeps everything that made 4.0 work and sharpens what matters: the core chat is ~40% more intelligent at the same speed, and the Regulatory Architect is 3x faster, ~25% smarter, and now wired directly into the CFR database for more accurate device classification. The Visualizer and Analytics engines get intelligence and speed bumps, and a wave of UI/UX updates came straight from how people used 4.0. Here's everything new in CLYTE's Sophie 4.5.

You asked to get CytCut onto your bench now instead of waiting, so here it is. CytCut 3.5 is available for immediate order at $36, in 24- and 48-well, the same wound healing assay tool that turns minutes of pipette scratching into seconds of consistent, reproducible wounds. It's UV- and alcohol-sanitizable with a 3–6 month working life. The autoclavable CytCut 4.0 is still on track for end of September at $99 pre-order. Order 3.5 with code cytcut352673 for $15 off through Jul

Stop searching for vague lab protocols. Soφ AI is the revolutionary, free AI assistant that instantly generates reliable, customized procedures for any biomedical assay. Simply input your specific materials—cell lines, reagents, and equipment—and Soφ AI delivers a dynamic, step-by-step protocol tailored just for you. It's designed to help researchers at all levels learn new techniques faster, troubleshoot experiments intelligently, and accelerate the pace of scientific discov

Soφ AI, the world's first AI lab assistant specifically engineered for biomedical and healthcare research! Soφ AI is set to revolutionize the industry by empowering scientists to overcome the reproducibility crisis, troubleshoot assays with ease, write detailed protocols, and analyze complex data. This is more than just a tool; it's a new partner in the lab that will accelerate the pace of discovery and usher in a new era of innovation in healthcare.

CLYTE Technologies is set to launch SOφ (Sophie), a groundbreaking AI biomedical lab assistant that will revolutionize the research industry. This cutting-edge AI can troubleshoot assays, write detailed protocols, and analyze data, empowering scientists to overcome the reproducibility crisis and accelerate the pace of discovery. SOφ is poised to be the next big thing in biomedical research, offering a level of support and expertise that is unmatched in the market. A new era o